Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule

Abstract excerpt

Abstract Background Lung adenocarcinoma (LADC) with epidermal growth factor receptor (EGFR) mutation is considered a subgroup of lung cancer sensitive to EGFR-targeted tyrosine kinase inhibitors. We aimed to develop and validate a computed tomography (CT)-based radiomics signature for prediction of EGFR mutation status in LADC appearing as a subsolid nodule. Materials and Methods A total of 467 eligible patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lung Cancer Diagnosis and Treatment
• Share to MRI in cancer diagnosis
• Share to Radiomics and Machine Learning in Medical Imaging